<style face="normal" font="default" size="100%">The combination of a novel immunomodulator with a regulatory T cell suppressing antibody (DTA-1) regress advanced stage B16F10 solid tumor by repolarizing tumor associated macrophages in situ.</style>

Drupal-Bibcite